Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Cells|December 17, 2024
Use of Artificial Intelligence in Imaging DementiaManal Aljuhani, Azhaar Ashraf, Paul EdisonBrain Communications|December 20, 2024
Evaluating clinical meaningfulness of anti-β-amyloid therapies amidst amyloid-related imaging abnormalities concern in Alzheimer's diseaseManal Aljuhani, Azhaar Ashraf, Paul EdisonCells|February 12, 2025
Cortical Diffusivity, a Biomarker for Early Neuronal Damage, Is Associated with Amyloid-β Deposition: A Pilot StudyJustine Debatisse, Fangda Leng, Azhaar Ashraf, et al.Frontiers in Neuroscience|March 26, 2019
Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer's DiseaseAzhaar Ashraf, Jose Andres Alepuz Guillen, Manal Aljuhani, et al.Neurology International|May 26, 2026
CSF Levels of Baseline VCAM-1 and ICAM-1 Are Associated with Tau Pathology in Patients Demonstrating Cognitive ImpairmentManal Aljuhani, Azhaar Ashraf, Abdullah Alqarni, et al.Frontiers in Aging Neuroscience|April 29, 2025
Cerebrospinal fluid levels of tumour necrosis factor-α and its receptors are not associated with disease progression in Alzheimer's diseaseManal AljuhaniNeurology International|July 27, 2026
Cerebrospinal Fluid Transforming Growth Factor β Isoforms and Disease Progression in Alzheimer's Disease: Longitudinal Evidence from the ADNI CohortManal Aljuhani, Azhaar Ashraf, Abdullah Alqarni, et al.Frontiers in Aging Neuroscience|August 8, 2020
Spotlight on Ferroptosis: Iron-Dependent Cell Death in Alzheimer's DiseaseAzhaar Ashraf, Po-Wah SoFrontiers in Aging Neuroscience|March 30, 2018
The Aging of Iron ManAzhaar Ashraf, Maryam Clark, Po-Wah SoRedox Biology|March 22, 2020
Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer's disease: Evidence of ferroptosisAzhaar Ashraf, Jérôme Jeandriens, Harold G Parkes, et al.Pageof 12